← Back to catalogue
Research draft

kidney cancer

vr.tr.kidney-cancer · XCT.STA

Let an agent explain kidney cancer and its types in general terms from oncology guidelines, describe risk factors, diagnosis and treatment approaches, distinguish adult and childhood forms, and route personal questions to clinicians.

Thing Registry Cross-cutting context

Research draft, second pass

A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.

written by Claude from model knowledge without web access - no source was read, every claim is a lead to verify

Researched by: Claude

Purpose and description

Let an agent explain kidney cancer and its types in general terms from oncology guidelines, describe risk factors, diagnosis and treatment approaches, distinguish adult and childhood forms, and route personal questions to clinicians.

Cancer arising in the kidney, chiefly renal cell carcinoma in adults, urothelial carcinoma of the renal pelvis, and in children Wilms tumour and rarer tumours such as mesoblastic nephroma and malignant cystic nephroma, with uncommon forms such as small cell carcinoma and catecholamine-producing tumours of adjacent adrenal tissue sometimes grouped with them; kidney cancer is often found incidentally on imaging, is treated by surgery, targeted therapy and immunotherapy, and has risk factors including smoking, obesity and hypertension.

What it is for: Not applicable; a group of cancers.

It can be explain types and risk factors; relay diagnosis and treatment approaches; distinguish adult and childhood forms; route personal questions.

Distinguishing features

Renal cell carcinoma dominance

Incidental detection

Surgery as main treatment

Distinct childhood tumours

What it looks like

Not a visible object; a tumour seen on imaging.

Physical character

new cases worldwide: about 430000 per year - GLOBOCAN 2022

renal cell carcinoma share: about 90 percent - of adult kidney cancers

How it is recognised

Malignant tumours of the kidney

Renal cell carcinoma, renal pelvis cancer, Wilms tumour and rare types

Benign kidney tumours and cysts are not cancer; bladder cancer is a separate urinary cancer

Related models

is a kind of - in registry terms

kidney neoplasm

is a kind of - in registry terms

urinary system cancer

is treated by - among other treatments

nephrectomy

is contrasted with - such as oncocytoma

benign kidney tumour

In practice

Families and kinds

renal cell carcinoma and its subtypes

urothelial carcinoma of the renal pelvis

Wilms tumour and other childhood kidney neoplasms

rare tumours such as mesoblastic nephroma, malignant cystic nephroma and small cell carcinoma

hereditary kidney cancer syndromes

Identifiers

ICD-11 2C90 malignant neoplasms of kidney

MeSH D007680 kidney neoplasms

Standards and regulation

Oncology guidelines from ESMO, NCCN and urological associations

Cancer registration standards

Drug approvals for targeted and immunotherapies

Failure modes and hazards

Late diagnosis

Agents giving personal medical advice

Confusing kidney cancer types

Overtreatment of small incidental masses

Also called

childhood kidney neoplasmrenal pelvis neoplasmcatecholamine-producing tumormalignant cystic nephromamesoblastic nephromakidney small cell carcinomahereditary Wilms' tumorkidney hemangiopericytomabenign metanephric tumournon-amyloid monoclonal immunoglobulin deposition diseasenephroblastomacongenital mesoblastic nephromarenal Wilms' tumormetachronous kidney Wilms' tumormixed cell type kidney Wilms' tumorblastema predominant kidney Wilms' tumorepithelial predominant Wilms' tumorstromal predominant kidney Wilms' tumorWilms' tumor 2Wilms' tumor 3adult kidney wilms tumorchildhood kidney wilms tumor

Where this came from

wikidata · CC0 1.0

Drafted structure

Bundle to layer to finding to question, as the second pass will find it: 4 bundles · 8 layers · 8 findings · 16 questions.

Help Getting help first.

Safety.

Signs

Warning signs.

Signs

Signs.

  1. What signs such as blood in the urine or flank pain need prompt assessment? action
  2. Is the user describing such signs, which need a clinician promptly? boundary

Care

Specialist care.

Care

Care.

  1. How is kidney cancer diagnosed and staged by specialists, in general terms? provenance
  2. Is the user asking about their own diagnosis, which needs their oncology team? boundary
Understand The cancers.

Clinical.

Types

Types and risk factors.

Types

Types.

  1. What types of kidney cancer exist, and what are the risk factors? definition
  2. Is the question about adult kidney cancer, a childhood tumour or a benign mass? boundary

Childhood

Childhood tumours.

Childhood

Childhood.

  1. What are Wilms tumour and other childhood kidney tumours, in general terms? provenance
  2. Which entry fits the specific tumour? action
Treat Treatment.

Clinical.

Treatment

Treatment.

Treatment

Treatment.

  1. What treatments do guidelines recommend, from surgery to targeted and immunotherapies, in general terms? provenance
  2. Which references are standard? provenance

Outcomes

Outcomes and follow-up.

Outcomes

Outcomes.

  1. What do statistics say about survival by stage, and how is follow-up organised? provenance
  2. Which sources are cited? provenance
Context Research and prevention.

Context.

Research

Research.

Research

Research.

  1. What research is advancing kidney cancer treatment, with findings attributed? provenance
  2. Which entry fits cancer immunotherapy? action

Prevention

Prevention.

Prevention

Prevention.

  1. What prevention advice do guidelines give, and what hereditary syndromes need screening? provenance
  2. Which entry fits hereditary kidney cancer? action

What the second pass must settle

  • Should renal cell carcinoma and Wilms tumour be separate primary entries?
  • How should guidelines be linked?
  • The registry entry has merged aliases naming rare tumours and an adrenal tumour type; should they be split off?